Type
. Epidermal keratinocyte Ia expression, Langerhans cell hyperplasia and lymphocytic infiltration in skin lesions of leprosy. Clinical and experimental immunology [Internet]. 1986;65(2):253-9. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1542316/pdf/clinexpimmunol00119-0041.pdf
Type
. Cloned suppressor T cells from a lepromatous leprosy patient suppress Mycobacterium leprae reactive helper T cells. Nature. 1986;322(6078):462-4.
Type
. [Anti-M. leprae antibodies and the serology of leprosy]. Acta leprologica. 1986;(102):331-41.
Type
. Learning from leprosy: a perspective on immunology and the Third World. Journal of immunology (Baltimore, Md. : 1950). 1986;137(1):i-x.
Type
. Use of synthetic glycoconjugates containing the Mycobacterium leprae specific and immunodominant epitope of phenolic glycolipid I in the serology of leprosy. Clinical and experimental immunology [Internet]. 1986;64(3):476-83. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1542453/pdf/clinexpimmunol00123-0028.pdf
Type
. A preliminary study on serological activity of a phenolic glycolipid from Mycobacterium leprae in sera from patients with leprosy, tuberculosis and normal controls. Leprosy review [Internet]. 1986;57(2):129-36. Available from: http://leprev.ilsl.br/pdfs/1986/v57n2/pdf/v57n2a05.pdf
Type
. M. leprae and PPD-triggered T cell lines in tuberculoid and lepromatous leprosy. Journal of immunology (Baltimore, Md. : 1950). 1986;136(11):4255-63.
Type
. [HLA system and relationship between microorganisms and host; an important factor in vaccination?]. Nederlands tijdschrift voor geneeskunde. 1986;130(17):772-5.
Type
. [Morphologic structure of Mycobacterium leprae]. Nihon Rai Gakkai zasshi. 1986;55(2):48-61.
Type
. Prevalence and specificity of the enhancing effect of three types of interleukin 2 on T cell responsiveness in 97 lepromatous leprosy patients of mixed ethnic origin. Clinical and experimental immunology [Internet]. 1986;64(1):41-9. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1542157/pdf/clinexpimmunol00121-0050.pdf
Pagination
- Previous page
- Page 2163
- Next page